Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

184.81
BATS BZX Real-Time Price
As of 2:48pm ET
 +0.95 / +0.52%
Today’s Change
150.06
Today|||52-Week Range
203.30
-0.12%
Year-to-Date

Today’s Trading

Previous close183.86
Today’s open184.00
Day’s range183.18 - 185.11
Volume850,108
Average volume (3 months)2,162,767
Market cap$40.8B
Dividend yield--
Data as of 2:32pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)-2.53%
Earnings growth (next 5 years)+19.69%
Revenue growth (last year)+46.49%
P/E ratio63.2
Price/Sales16.84
Price/Book10.90

Competitors

 Today’s
change
Today’s
% change
SHPGShire+2.39+0.98%
MYLMylan NV+0.31+0.44%
VRTXVertex Pharmaceutica...+4.71+3.73%
PRGOPerrigo Company PLC-1.18-0.64%
Data as of 2:46pm ET, 07/02/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)$1.39
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Chief Financial Officer &
Executive Vice President
Vikas Sinha
Corporate headquarters
Cheshire, Connecticut

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers